Search Results - Pedro Sanchez-Godoy

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.

    Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia. by Carol Lozano-Santos, Jimena Martinez-Velasquez, Belen Fernandez-Cuevas, Natividad Polo, Belen Navarro, Isabel Millan, Jose Miguel Garcia, Rosa Collado, Pedro Sanchez-Godoy, Felix Carbonell, Jose Antonio Garcia-Vela, Jose Antonio Garcia-Marco, Natalia Gomez-Lozano

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.

    PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. by Juan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, Maria Teresa Gomez-Casares, Ismael Buño, Francisca Ferrer-Marín, Alicia Arenas, Rafael Del Orbe, Rosa Ayala, Pilar Llamas, Rocio N Salgado, Santiago Osorio, Pedro Sanchez-Godoy, Carmen Burgaleta, Ignacio Mahíllo-Fernández, Valentin Garcia-Gutierrez, Juan Luis Steegmann, Joaquín Martinez-Lopez

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

    Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy by Eva Barragán, Pau Montesinos, Mireia Camos, Marcos González, Maria J. Calasanz, José Román-Gómez, Maria T. Gómez-Casares, Rosa Ayala, Javier López, Óscar Fuster, Dolors Colomer, Carmen Chillón, María J. Larrayoz, Pedro Sánchez-Godoy, José González-Campos, Félix Manso, Maria L. Amador, Edo Vellenga, Bob Lowenberg, Miguel A. Sanz

    Published 2011-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

    Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study by Julio García-Suárez, Javier de la Cruz, Ángel Cedillo, Pilar Llamas, Rafael Duarte, Víctor Jiménez-Yuste, José Ángel Hernández-Rivas, Rodrigo Gil-Manso, Mi Kwon, Pedro Sánchez-Godoy, Pilar Martínez-Barranco, Blanca Colás-Lahuerta, Pilar Herrera, Laurentino Benito-Parra, Adrián Alegre, Alberto Velasco, Arturo Matilla, María Concepción Aláez-Usón, Rafael Martos-Martínez, Carmen Martínez-Chamorro, Keina Susana-Quiroz, Juan Francisco Del Campo, Adolfo de la Fuente, Regina Herráez, Adriana Pascual, Elvira Gómez, Jaime Pérez-Oteyza, Elena Ruiz, Arancha Alonso, José González-Medina, Lucía Núñez Martín-Buitrago, Miguel Canales, Isabel González-Gascón, María Carmen Vicente-Ayuso, Susana Valenciano, María García Roa, Pablo Estival Monteliu, Javier López-Jiménez, Cristián Escolano Escobar, Javier Ortiz-Martín, José Luis Diez-Martin, Joaquín Martinez-Lopez, the Asociación Madrileña de Hematología y Hemoterapia (AMHH)

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: